Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

Summary

GBI Research’s report, “Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape” provides detailed insight into the American API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The API Market revenues in the Americas are expected to grow at a Compounded Annual Growth Rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, the API market revenues are expected to witness a steady growth. The faster growing markets of South and Central America will have greater contribution to the overall Americas API market growth. Brazil, especially, is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

Scope

- Market revenue data for APIs from 2005 to 2010 and forecast for six years to 2016
- API markets in key countries in the region: the US, Canada, Mexico and Brazil
- API industry structure and market trends such as shift of market from branded to generic and rise of biotechnology in the American region
- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the region’s key countries
- Information on the competitive landscape, with shares of leading companies such as Pfizer Inc., Astrazeneca International, GlaxoSmithKline Pharmaceuticals Ltd., Roche and Sanofi Aventis
- Analysis of API revenue based on product types in the American market and in key countries of the region.
- Analysis of API revenue based on therapeutic categories in the key countries.

Reasons to buy

- Develop business strategies with the help of specific insights on the American API market.
- Identify opportunities and challenges in the American API market.
- Invest in the growing segments of the API market.
- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the American API market.
- Benchmark your operations and strategies against the major players in the global API market.

Table Of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 GBI Report Coverage 11
3 Americas API Market 12
3.1 Americas API Industry Structure 12
3.2 Americas API Industry Challenges 13
3.2.1 Economic Downturn has Restricted Investment in Pharmaceutical Industry 13
3.2.2 High Costs Hinder New Drug Development in the Region 13
3.2.3 Maturity of Synthetic APIs Hamper Profit Margin Growth 13
3.2.4 Regulatory Changes Lead to Delays in the Launch of New Drugs in the Market 13
3.2.5 Patent Expiries of Best Selling Drugs Threatens Revenue Growth 13
3.3 Americas API Industry Trends 13
3.3.1 Patent Expiries are Changing Pharmaceutical Market Dynamics in America 13
3.3.2 Specialty Driven Products are Expected to Play an Important Role in the American API Market 13
3.3.3 Outsourcing of API Manufacturing is Growing Fast in America 14
3.3.4 Mergers and Acquisitions (MandA) Activities have Increased Significantly in the American Pharmaceutical Industry 14
3.4 Americas API Market Revenue Analysis and Forecasts to 2016 15
3.5 Americas API Market Revenue Share Analysis by Product Type and Forecasts to 2016 17
3.5.1 Americas API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 18
3.5.2 Americas API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 19
3.6 Americas API Market Revenue Share Analysis by Country and Forecasts to 2016 20
3.7 North America API Market 21
3.7.1 North America API Market Overview 21
3.7.2 North America API Market Drivers 21
3.7.3 North America API Market Restraints 21
3.7.4 North America API Market Revenue Analysis and Forecasts to 2016 23
3.7.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 25
3.7.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2016 31
3.8 North America API Market Competitive Landscape 32
3.9 South and Central America API Market 34
3.9.1 South and Central America API Market Overview 34
3.9.2 South and Central America API Market Drivers 34
3.9.3 South and Central America API Market Restraints 35
3.9.4 South and Central America API Market Revenue Analysis and Forecasts to 2016 35
3.9.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 37
3.9.6 South and Central America API Market Revenue Share Analysis by Country and Forecasts to 2016 43
3.9.7 South and Central America API Market Competitive Landscape 44
4 The US API Market 45
4.1 The US API Market Overview 45
4.2 The US API Market Drivers 45
4.2.1 The Rising Incidence of Lifestyle and Old Age Diseases is Giving Rise to API Demand in the Region 45
4.2.2 Growth in Oncology is One of the Major Contributing Factors to the Growth of APIs in the Region 45
4.2.3 Growth in Biotechnology will Favor Growth of API Market Revenues 45
4.2.4 Increasing Focus on High Potency APIs Helps Market Growth 45
4.3 The US API Market Restraints 45
4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the US 45
4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of the US API Market 46
4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversely Affect the Growth of the API Market in the Region 46
4.3.4 Rising Competition from China and India is Creating Price Pressure in the US Market 46
4.4 The US API Market Revenue Analysis and Forecasts to 2015 46
4.5 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015 48
4.5.1 The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 48
4.5.2 The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 51
4.6 The US API Market Revenue Share Analysis by Therapeutic Category 54
4.7 The US API Market SWOT Analysis 55
4.7.1 Strengths 55
4.7.2 Weaknesses 55
4.7.3 Opportunities 56
4.7.4 Threats 56
5 Canada API Market 57
5.1 Canada API Market Overview 57
5.2 Canada API Market Drivers 57
5.2.1 Government Support for Increasing Healthcare Standards Encourages API Market Growth 57
5.2.2 Fast Growing Biotechnology Industry in the Country Increases Demand for APIs 57
5.2.3 Growth in Old Age Population in Canada Provides Leads to Growth of the API Market 57
5.3 Canada API Market Restraints 57
5.3.1 Patent Expiries of Some Blockbuster Drugs Will Negatively Impact the API Market 57
5.3.2 Price Controls by the Government Affects API Market Revenues 57
5.4 Canada API Market Revenue Analysis and Forecasts to 2015 58
5.5 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015 59
5.5.1 Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 59
5.5.2 Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 62
5.6 Canada API Market Revenue Share Analysis by Therapeutic Category 65
5.7 Canada API Market SWOT Analysis 66
5.7.1 Strengths 66
5.7.2 Weaknesses 66
5.7.3 Opportunities 67
5.7.4 Threats 67
6 Mexico API Market 68
6.1 Mexico API Market Overview 68
6.2 Mexico API Market Drivers 68
6.2.1 Strong Growth in Pharmaceutical Market Leads the API Market in Mexico 68
6.2.2 Rapid Growth in Generics Market Encouraging API Demand 68
6.3 Mexico API Market Restraints 68
6.3.1 Patent Expiries of Blockbuster Drugs will Negatively Impact Market Revenue Growth 68
6.3.2 The Problem of Counterfeits Challenging the Market 68
6.4 Mexico API Market Revenue Analysis and Forecasts to 2015 69
6.5 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2015 70
6.5.1 Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 70
6.5.2 Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 73
6.6 Mexico API Market Revenue Share Analysis by Therapeutic Category 76
6.7 Mexico API Market SWOT Analysis 77
6.7.1 Strengths 77
6.7.2 Weaknesses 77
6.7.3 Opportunities 78
6.7.4 Threats 78
7 Brazil API Market 79
7.1 Brazil API Market Overview 79
7.2 Brazil API Market Drivers 79
7.2.1 Strongly Growing Economy Gives Boost to the API Market 79
7.2.2 Increase in Old Age Population Gives Rise to APIs Demand 79
7.2.3 Rapidly Growing Demand for Generic Drugs will Drive the Country’s API Market 79
7.3 Brazil API Market Restraints 79
7.3.1 Delay in Drug Approvals Hinders the Market Growth 79
7.3.2 The Dependency on Imports for Pharmaceutical Raw Materials Restricts Market Growth 79
7.4 Brazil API Market Revenue Analysis and Forecasts to 2015 80
7.5 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2015 81
7.5.1 Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 81
7.5.2 Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 84
7.6 Brazil API Market Revenue Share Analysis by Therapeutic Category 87
7.7 Brazil API Market SWOT Analysis 88
7.7.1 Strengths 88
7.7.2 Weaknesses 89
7.7.3 Opportunities 89
7.7.4 Threats 89
8 Appendix 90
8.1 Abbreviations 90
8.2 Methodology 90
8.2.1 Coverage 90
8.2.2 Secondary Research 91
8.2.3 Primary Research 91
8.2.4 Expert Panel Validation 91
8.3 Contact Us 91
8.4 About GBI Research 92
8.5 Disclaimer 921.1 List of Tables
Table 1: API Market, Americas, Revenues, $m, 2005-2016 16
Table 2: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 18
Table 3: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 19
Table 4: API Market, Americas, Revenue Share by Country, %, 2010 and 2016 20
Table 5: API Market, North America, Major Drugs to Lose Patent Protection, 2011 and 2012 22
Table 6: API Market, North America, Revenues, $m, 2005-2016 24
Table 7: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 25
Table 8: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016 27
Table 9: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 28
Table 10: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 30
Table 11: API Market, North America, Revenue Share by Country, %, 2010 and 2016 31
Table 12: API Market, North America, Competitive Landscape, %, 2010 33
Table 13: API Market, South and Central America, Revenues, $m, 2005-2016 36
Table 14: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 37
Table 15: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 39
Table 16: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 40
Table 17: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 42
Table 18: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016 43
Table 19: API Market, The US, Revenues, $m, 2005-2016 47
Table 20: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 48
Table 21: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 50
Table 22: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 51
Table 23: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016 53
Table 24: API Market, The US, Revenue Share by Therapeutic Category, %, 2010 54
Table 25: API Market, Canada, Revenues, $m, 2005-2016 58
Table 26: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 59
Table 27: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016 61
Table 28: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 62
Table 29: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016 64
Table 30: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010 65
Table 31: API Market, Mexico, Revenues, $m, 2005-2016 69
Table 32: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016 70
Table 33: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016 72
Table 34: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016 73
Table 35: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016 75
Table 36: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010 76
Table 37: API Market, Brazil, Revenues, $m, 2005-2016 80
Table 38: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 81
Table 39: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 83
Table 40: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 84
Table 41: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016 86
Table 42: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010 871.2 List of Figures
Figure 1: API, Global, Industry Value Chain, 2010 12
Figure 2: API Market, Americas, Revenues, $m, 2005-2016 15
Figure 3: API Market, Americas, Product Type, 2010 17
Figure 4: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 18
Figure 5: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 19
Figure 6: API Market, Americas, Revenue Share by Country, %, 2010 and 2016 20
Figure 7: API Market, North America, Revenues, $m, 2005-2016 23
Figure 8: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 25
Figure 9: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016 26
Figure 10: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 28
Figure 11: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 29
Figure 12: API Market, North America, Revenue Share by Country, %, 2010 and 2016 31
Figure 13: API Market, North America, Competitive Landscape, %, 2010 32
Figure 14: API Market, South and Central America, Revenues, $m, 2005-2016 35
Figure 15: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 37
Figure 16: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 38
Figure 17: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 40
Figure 18: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 41
Figure 19: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016 43
Figure 20: API Market, The US, Revenues, $m, 2005-2016 46
Figure 21: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 48
Figure 22: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 49
Figure 23: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 51
Figure 24: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016 52
Figure 25: API Market, The US, Revenue Share by Therapeutic Category, %, 2010 54
Figure 26: API Market, The US, SWOT, 2010 55
Figure 27: API Market, Canada, Revenues, $m, 2005-2016 58
Figure 28: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 59
Figure 29: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016 60
Figure 30: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 62
Figure 31: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016 63
Figure 32: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010 65
Figure 33: API Market, Canada, SWOT, 2010 66
Figure 34: API Market, Mexico, Revenues, $m, 2005-2016 69
Figure 35: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016 70
Figure 36: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016 71
Figure 37: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016 73
Figure 38: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016 74
Figure 39: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010 76
Figure 40: API Market, Mexico, SWOT Analysis, 2010 77
Figure 41: API Market, Brazil, Revenues, $m, 2005-2016 80
Figure 42: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 81
Figure 43: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 82
Figure 44: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 84
Figure 45: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016 85
Figure 46: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010 87
Figure 47: API Market, Brazil, SWOT Analysis, 2010 88

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Strategic Analysis of the Global MES Market

Strategic Analysis of the Global MES Market

  • $ 15 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Regional Trends Stimulate Growth, with Sustainable Profits from Installed Base-related Services The pressing need to replicate manufacturing plants and facilities across global locations and the requirements ...

Cloud Solutions and Market Opportunities

Cloud Solutions and Market Opportunities

  • $ 9 995
  • Industry report
  • September 2014
  • by Mind Commerce Publishing

Overview: Cloud computing abstracts and virtualizes the need for as much physical computing as possible and then it dynamically provisions that computing so that it can change to meet user demands. Based ...

Analysis of the Endpoint Security Market

Analysis of the Endpoint Security Market

  • $ 6 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Market Maturity & Product Efficacy Questions Dampen Prospects The efficacy of traditional antivirus-based endpoint protection is beginning to be challenged. While it is true that the role of traditional ...

Telco Cloud

October 2014 $ 3 750

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.